NCT06551987 is a NA clinical trial of Cognitive Behavioral Therapy for Insomnia in Insomnia, sponsored by The University of Texas Health Science Center at San Antonio.

Who is sponsoring NCT06551987?

NCT06551987 is sponsored by The University of Texas Health Science Center at San Antonio.

What drugs are being tested in NCT06551987?

Interventions in NCT06551987: Cognitive Behavioral Therapy for Insomnia, Brief Behavioral Therapy for Insomnia.

What condition does NCT06551987 study?

NCT06551987 studies Insomnia, Mild Traumatic Brain Injury.

Is NCT06551987 still recruiting?

NCT06551987 is currently recruiting now. Last updated 7 January 2026.

Last reviewed 2026-01-07 · How we verify

NCT06551987

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Behavioral Insomnia Treatment in Mild Traumatic Brain Injury

Recruiting now NA Last updated 7 January 2026

What this trial tests

NA trial testing Cognitive Behavioral Therapy for Insomnia in Insomnia in 160 participants. Currently enrolling.

Timeline

3 December 2024

Primary endpoint
1 February 2027

1 September 2027

Quick facts

Lead sponsor	The University of Texas Health Science Center at San Antonio
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	160
Start date	3 December 2024
Primary completion	1 February 2027
Estimated completion	1 September 2027
Sites	1 location across United States

Drugs / interventions tested

Cognitive Behavioral Therapy for Insomnia
Brief Behavioral Therapy for Insomnia

Conditions studied

Insomnia — all drugs for Insomnia →
Mild Traumatic Brain Injury — all drugs for Mild Traumatic Brain Injury →

Sponsor

The University of Texas Health Science Center at San Antonio

Who can join

Adults 18 to 45, any sex, with Insomnia or Mild Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single site, two-armed random controlled trials (RCT) comparing six sessions of Cognitive Behavioral Therapy for Insomnia (CBT-I) with four sessions of Brief Behavioral Therapy for Insomnia (BBT-I) in service members with comorbid insomnia and prolonged postconcussive symptoms present for at least 3 months after Mild Traumatic Brain Injury (mTBI).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cognitive Behavioral Therapy for Insomnia

Trials testing the same drug.

NCT07062406 — Enhancing Diabetes Care by Treating Insomnia · NA · not yet recruiting
NCT07335276 — Enhancing Operational Readiness With Digital Self-Managed Cognitive Behavioral Therapy for Insomnia (CBTI) · NA · not yet recruiting
NCT07230899 — Cognitive Behavioural Therapy for Insomnia Among Young People With Moderate Level of Mental Distress in Hong Kong · NA · not yet recruiting
NCT07156383 — Restorative Effects of Sleep on Everyday Health and Wellbeing: A Treatment Study · NA · not yet recruiting
NCT07076342 — The Role of mGluR5 in CBT-I · Phase 4 · recruiting

Other recruiting trials for Insomnia

Currently open trials in the same condition.

NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
NCT07071324 — CF Wellness Program · NA · recruiting
NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting

Other The University of Texas Health Science Center at San Antonio trials

Trials by the same sponsor.

NCT07280897 — SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial · NA · not yet recruiting
NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
NCT07056699 — SGLT2i, Pioglitazone, and Ketone Production in T1D · Phase 3 · not yet recruiting
NCT06609343 — Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis · Phase 1, PHASE2 · not yet recruiting
NCT07437053 — Sarcopenia in Chronic Kidney Disease (CKD) Patients · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06551987 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center at San Antonio
Last refreshed: 7 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06551987.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing